Skip to main content
PLOS Neglected Tropical Diseases logoLink to PLOS Neglected Tropical Diseases
. 2020 Jun 22;14(6):e0008293. doi: 10.1371/journal.pntd.0008293

Unusual dominant genotype NIA1 of Enterocytozoon bieneusi in children in Southern Xinjiang, China

Meng Qi 1,2, Fuchang Yu 1, Aiyun Zhao 2, Ying Zhang 2, Zilin Wei 2, Dongfang Li 1, Longxian Zhang 1,*
Editor: Abdallah M Samy3
PMCID: PMC7332067  PMID: 32569279

Abstract

Enterocytozoon bieneusi is the mainly pathologies or intestinal disorders that causes approximately 90% of reported cases of human microsporidiosis. To understand the prevalence and genotype distribution of E. bieneusi in the Xinjiang Uygur Autonomous Region, China, 609 fecal samples were collected from children in kindergarten in Southern Xinjiang and screened for this pathogen by PCR and sequencing of the internal transcribed spacer (ITS). Thirty-six fecal samples (5.9%, 36/609) were positive for E. bieneusi, with the highest prevalence observed in children from Yopurga (17.5%, 11/63). Nine genotypes were identified, of which six were known (A, CHN6, D, EbpA, KB-1, and NIA1) and three were novel (CXJH1, CXJH2 and CXJH3). Genotype NIA1 was most prevalent (52.8%, 19/36), followed by genotypes D (16.7%, 6/36), A (8.3%, 3/36), and EbpA (8.3%, 3/36). The remaining five genotypes were detected in one sample each. Phylogenetic analysis revealed that the E. bieneusi isolates clustered into two groups, one consisting of six genotypes (Group 1: A, CXJH1, D, EbpA, KB-1, and NIA1) and another consisting of three genotypes (Group 2: CHN6, CXJH2, and CXJH3). Our results confirmed that infection of E. bieneusi unusual dominant genotype NIA1 occurs in children in Xinjiang, China. Further epidemiological studies must be conducted to clarify potential sources of E. bieneusi infection in this area.

Author summary

This study reports the infection rates and genetic characteristics of Enterocytozoon bieneusi in 609 children in kindergarten in Southern Xinjiang, China. All samples were screened for this pathogen with PCR, based on the internal transcribed spacer (ITS) of E. bieneusi. Thirty-six fecal samples (5.9%, 36/609) were positive, with the highest prevalence observed in children from Yopurga (17.5%, 11/63). Three novel genotypes were identified (CXJH1, CXJH2 and CXJH3). Phylogenetic analysis revealed that the E. bieneusi isolates clustered into two groups: Group 1 (A, CXJH1, D, EbpA, KB-1, and NIA1) and Group 2 (CHN6, CXJH2, and CXJH3). Genotype NIA1 used to be detected in HIV-positive patients, however, it was most prevalent (52.8%, 19/36) among the nine genotypes identified in this study. Additionally, we confirmed the zoonotic potential of E. bieneusi genotype D and this is the first report of human infection by E. bieneusi genotypes KB-1 and CHN6.

Introduction

Microsporidia are fungal obligate intracellular pathogens. Among at least 10 genera including 17 species infecting humans, Enterocytozoon bieneusi is the most frequently detected pathogen causing microsporidiosis [1]. Infection by E. bieneusi may have no symptoms or may cause persistent diarrhea, vomiting and a wasting syndrome, dissemination and presence in other organs, particularly in immunocompromised individuals such as human immunodeficiency virus (HIV)-infected individuals, organ transplant recipients or cancer patients. Travelers, children, and older adults are also at risk [2].

Currently, analysis of polymorphisms within the ribosomal internal transcribed spacer (ITS) is most commonly used for genotyping of E. bieneusi. Over 474 ITS genotypes have been identified, of which more than 96 have been detected in humans [3, 4]. Phylogenetic analysis indicated that these genotypes clustered into 11 groups (Group 1–11). Most E. bieneusi isolates causing human infections belonged to the zoonotic Group 1 [5]. Nevertheless, there is an increasing number of reports have been showing that some Group-2-genotypes (I, J, BEB4 and BEB6) firstly detected in livestock or wild animals can also infect humans [3, 4]. Genotypes of other groups appear to be more host-specific, suggesting a low level of potential for zoonotic or cross-species transmission. However, this hypothesis needs to be confirmed because little information is available regarding these groups [4].

In 2011, the first report emerged of E. bieneusi infecting humans in Jilin, China [6], with 22.5% (9/40) of children with diarrheal disease testing positive for this pathogen. Over the last decade, the prevalence and genotype distribution of E. bieneusi in humans in China have been reported by several studies [615]. The study participants had widely variable characteristics (children with or without diarrhea, HIV-positive or -negative individuals, and other immunocompromised patients) [615] and the studies were conducted in diverse geographical locations (Jilin, Heilongjiang, Guangxi, Henan, Shanghai, Hubei, Chongqing, and Yunnan). However, no data are available regarding the prevalence and genetic characteristics of E. bieneusi isolates in the Xinjiang Uygur Autonomous Region (hereafter referred to as Xinjiang), China. Herein, we conducted a molecular epidemiological study of E. bieneusi, via sequencing of the ITS region, to understand the prevalence and genotypes of this pathogen in children in Xinjiang.

Materials and Methods

Ethics statement

All procedures complied with the ethical standards of the relevant national and institutional committees on human experimentation and with the principles laid out in the Helsinki Declaration of 1975, as revised in 2013. The study was approved by the Institutional Review Board of Henan Agricultural University (Approval No: IRC-HENAU-20160224-05). Written informed consent for participation in the study was obtained from the parent or guardian of each child after they were informed of the purposes and procedures of the study. Participants with possible presence of parasites received appropriate treatment according to local policies and national guidelines.

Sample collection

The study was conducted from August 2017 to January 2019. Fresh stool samples were collected from children (age range: 2 to 6 years) at kindergartens in 11 counties in Southern Xinjiang (Fig 1). After being informed of the study purpose and procedures by kindergarten staff, parents or guardians who agreed to their children’s participation were given a plastic fecal collector labeled with a unique number. Fresh stool samples were collected in the morning. The fecal collector was then marked with the date and the participant’s name, age, and sex. No diarrhea was observed during sampling. In total, 609 fecal samples were collected, transported to the laboratory and stored at 4°C.

Fig 1. Geographic map of the sampling locations in Xinjiang, China.

Fig 1

The figure was originally designed by the authors under the software ArcGIS 10.2. The original vector diagram imported in ArcGIS was adapted from Natural Earth (http://www.naturalearthdata.com).

DNA extraction and PCR amplification

Fresh fecal samples were processed within 24 h of transport to the laboratory. Genomic DNA was extracted from ~200 mg of each stool sample using the E.Z.N.A stool DNA kit (Omega Bio-tek, Norcross, GA) in accordance with the manufacturer’s instructions. Extracted DNA was stored at -20°C until PCR was performed.

All samples were screened for the presence of E. bieneusi using a nested PCR targeting a ~390-bp fragment of the ITS in accordance with the method described by Sulaiman et al. [16] with some optimization. PCR was performed in 25-μl reaction mixtures consisting of 2 μL of DNA preparation (or first PCR product), 1× PCR buffer, 200 μM dNTPs, 3 mM MgCl2, 260 nM primers, and 1.5 units of Taq DNA polymerase (Takara, Tokyo, Japan). PCR was performed in an Applied Biosystems 2720 thermal cycler (Applied Biosystems, Foster City, USA) using a program of 35 cycles, each consisted of denaturation at 94°C for 35 s, annealing at 55°C for 45 s, and extension for 45 s at 72°C; an initial denaturation step of 95°C for 5 min and a final extension step of 72°C for 10 min were also included. Outer primers were EBITS3 (5’-GGTCATAGGGATGAAGAG-3’) and EBITS4 (5’-TTCGAGTTCTTTCGCGCTC-3’); EBITS1 (5’-GCTCTGAATATCTATGGCT-3’) and EBITS2.4 (5’-ATCGCCGACGGATCCAAGTG-3’) were used as nested primers for secondary PCR. Reagent-grade water and E. bieneusi-positive DNA (dairy cattle-derived genotype I DNA) were used as negative and positive controls, respectively.

Sequence and phylogenetic analyses

Positive secondary PCR products were sequenced bidirectionally by GENEWIZ (Suzhou, China). The obtained sequences were assembled and edited using DNASTAR Lasergene EditSeq version 7.1.0 (http://www.dnastar.com/) and aligned with reference sequences downloaded from GenBank in the software Clustal X version 2.1 (http://www.clustal.org/).

The typical length of E. bieneusi ITS nucleotide sequence was 243 bp. Phylogenetic relationships were inferred by constructing a phylogenetic tree using Bayesian inference (BI) and the Monte Carlo Markov Chain method in MrBayes v3.2.6 (http://mrbayes.sourceforge.net/) and Fig-Tree v1.4.4 (http://tree.bio.ed.ac.uk/software/figtree/). Posterior probabilities were estimated based on 1,000,000 generations with four simultaneous tree building chains, with trees saved every 100th generation. A 50% majority rule consensus tree for each analysis was constructed based on the final 75% of trees generated using BI.

Statistical analyses

Prevalence of E. bieneusi with an associated 95% confidence interval (CI) was calculated using IBM SPSS Statistics (www.ibm.com/products/spss-statistics). Fisher’s exact test was used to compare the prevalence of E. bieneusi in different groups. A two-sided p-value of ≤0.05 was considered statistically significant.

Nucleotide sequence accession numbers

All nucleotide sequences obtained in this study were deposited in GenBank under accession numbers MN136770 to MN136778.

Results

Prevalence of E. bieneusi

Of the 609 fecal samples analyzed by nested PCR, 36 were positive for E. bieneusi, yielding an overall prevalence 5.9% (95% CI 4.0–7.9%). E. bieneusi-positive samples were detected in eight of the 11 counties involved in this study (Table 1). The highest prevalence was observed in Yopurga (17.5%, 11/63; 95% CI: 7.3–27.7%) followed by Baicheng (13.0%, 3/23; 95% CI: 0–29.0%). Prevalence ranged from 1.6% to 9.0% in the remaining six counties, and E. bieneusi was not detected in Hotan, Poskam or Kuqa (Table 1). Differences in E. bieneusi prevalence among counties in which the parasite was detected were statistically significant (p = 0.043).

Table 1. Prevalence and genotype distribution of E. bieneusi among children in different counties of southern Xinjiang.

County No. of positives/ No. of samples Prevalence (%) (95% CI) Genotype (n)
Tumushuke 1/62 1.6 (0–5.6) NIA1 (1)
Payzawat 2/25 8.0 (0–20.6) NIA1 (2)
Shufu 3/48 6.3 (0–14.1) D (1), NIA1 (2)
Yopurga 11/63 17.5 (7.3–27.7) CXJH1 (1), D (4), NIA1 (6)
Yecheng 8/89 9.0 (2.5–15.5) A (3), D (1), NIA1 (4)
Hotan 0/80 0
Baicheng 3/23 13.0 (0–29.0) CHN6 (1), CXJH2 (1), CXJH3 (1)
Poskam 0/35 0
Kuqa 0/38 0
Pishan 3/37 8.1 (0–18.3) EbpA (2), NIA1 (1)
Lop 5/109 4.6 (0.2–9.0) EbpA (1), KB-1 (1), NIA1 (3)
Total 36/609 5.9 (4.0–7.9) A (3), CHN6 (1), CXJH1 (1), CXJH 2 (1), CXJH 3 (1), D (6), EbpA (3), KB-1 (1), NIA1 (19),

E. bieneusi was detected in 6.7% (20/299, 95% CI: 3.7%–9.7%) and 5.2% (16/310, 95% CI: 2.5%–7.8%) of samples from boys and girls, respectively. Prevalence differences between gender groups were not significant (p > 0.05) (Table 2).

Table 2. Prevalence and genotype distribution of E. bieneusi among children in southern Xinjiang by gender.

Gender No. of positives/ No. of samples Prevalence (%) (95% CI) Genotype (n)
Boy 20/299 6.7 (3.7–9.7) A (2), CHN6 (1), D (3), EbpA (1), NIA1 (13)
Girl 16/310 5.2 (2.5–7.8) A (1), CXJH1 (1), CXJH 2 (1), CXJH 3 (1), D (3), EbpA (2), KB-1 (1), NIA1 (6),

Genotype distribution of E. bieneusi

Nucleotide sequences of the ITS were analyzed for all 36 E. bieneusi PCR-positive samples. The results revealed nine distinct genotypes, including six known genotypes (A, CHN6, D, EbpA, KB-1, and NIA1) and three novel genotypes (CXJH1, CXJH2 and CXJH3) (Table 1). NIA1 was the most frequently-detected genotype (n = 19), followed by genotypes D (n = 6), A (n = 3), and EbpA (n = 3). The remaining genotypes were detected in one sample each.

Phylogenetic analysis

Compared with genotype NIA1 (EF428628), the novel genotype CXJH1 displayed a single nucleotide polymorphism (SNP) at position 17 (G→A) of the ITS sequence. Genotypes CXJH2 and CXJH3 were characterized by two SNPs each (A43G and T201C in CXJH2; A3G and A43G for CXJH3) compared with genotype CHN6 (HM992514). Phylogenetic analysis was performed using the ITS region sequences to understand the genetic relationships among the novel E. bieneusi genotypes identified in this study and known genotypes. Genotypes NIA1, D, KB-1, A, EbpA, and the novel genotype CXJH1 clustered into one group (Group 1) and the remaining three genotypes (CHN6, CXJH2, and CXJH3) clustered in Group 2 together with the zoonotic genotypes I, J, and BEB6 (Fig 2).

Fig 2. Bayesian phylogenetic analysis of E. bieneusi ITS sequences.

Fig 2

Statistically significant posterior probabilities are indicated at branches. Sample names include GenBank accession number followed by host and then genotype designation. The E. bieneusi genotype CSK2 (KY706128) from red kangaroo was used as the outgroup. Known and novel genotypes identified in this study are indicated by squares and triangles, respectively.

Discussion

The average prevalence of E. bieneusi measured in humans in China is approximately 5.8% [17], with the highest prevalence (22.5%, 9/40) reported in Changchun [6] and the lowest (0.2%, 1/500) in Wuhan [12]. The prevalence of E. bieneusi detected in the present study was 5.9%, and similar results have been reported in several previous studies. For example, in a previous study, the prevalence of E. bieneusi in children of various age categories and clinical presentations was 7.5% (19/225) [10]. Similar prevalence was also reported in a contrast study conducted in Henan Province in China, in which 683 HIV-negative and 683 HIV-positive individuals were screened for the presence of E. bieneusi; 4.2% (29/683) and 5.7% (39/683), respectively, tested positive for this parasite [8]. However, higher prevalence has also been reported in China, such as in a study which found that 11 of 93 (11.8%) fecal specimens collected from children with diarrheal disease in Chongqing were positive for E. bieneusi [14]. Large differences in E. bieneusi prevalence in different regions in China have been reported by many studies, but the reasons underlying these differences remain unclear. E. bieneusi prevalence is associated with many factors, including but not limited to the immune status of the host, healthcare level, economic status and living conditions [13]. To determine the specific factors responsible for prevalence differences, more epidemiological investigations will need to be conducted.

In this study, E. bieneusi NIA1 was the most frequently-detected genotype (52.8%, 19/36). NIA1 was first detected in an HIV-positive patient in Niamey, Niger in 2007 [18]. Subsequently, NIA1 was detected in two hospitalized Acquired Immune Deficiency Syndrome (AIDS) patients in the Democratic Republic of the Congo in 2010 [19], one HIV-positive patient in China in 2011 [20], and one HIV-positive patient in the Democratic Republic of the Congo in 2012 [21]. Surprisingly, E. bieneusi NIA1 has only been identified in HIV-positive patients in previous studies, but was the dominant genotype (52.8%, 19/36) in children in Southern Xinjiang in this study. Whether there is a correlation between the genotype NIA1 and the immune status of local children, or a geographical role in the distribution of this genotype, requires further investigation.

Genotype D was the second most prevalent genotype detected in this study. According to the few reports of human infection by this genotype in China, genotype D was frequently detected in children with diarrhea, HIV-positive patients, and HIV-negative individuals in Shanghai, Henan, Hubei, and Guangxi [7, 8, 11, 12]. Additionally, genotype D has also been detected in humans in at least 21 countries worldwide [4] and in a vast range of animal species including companion animals, livestock, wildlife, rodents, and birds [4, 13]. In addition, genotype D has been detected in river water, wastewater, and combined sewer overflow in China [2224] as well as in wastewater in Spain and Tunisia [25, 26]. Therefore, the zoonotic potential of E. bieneusi genotype D is established, and its transmission via the indirect fecal–oral route is a strong possibility.

Among the remaining known genotypes, KB-1, CHN6, and EbpA were first identified in nonhuman primates (NHPs), dogs, and pigs, respectively [6, 27, 28]. Genotype EbpA has been detected in many hosts, including NHPs, sheep, goats, deer, dairy cattle, and humans [4]. Moreover, in one of our previous studies genotypes D and EbpA have been detected in pigs in the same geographical area of Xinjiang (China) [29]. This may indicate the animal origin of E. bieneusi in this area. Since all the samples involved here were collected from counties in rural area, the role of livestock in the circulation of this pathogen is nonnegligible in Xinjiang, China. Interestingly, ours is the first report of human infection by E. bieneusi genotypes KB-1 and CHN6.

According to the phylogenetic tree inferred in our study, the novel genotype CXJH1 clustered together with genotypes KB-1, A, and NIA1 in Group 1, potentially reflecting the zoonotic potential of these four genotypes. In contrast, genotypes CXJH2 and CXJH3 clustered together with genotype CHN6 in Group 2. Previous studies suggested that Group 2 was composed of E. bieneusi genotypes identified in ruminants. However, Group 2 genotypes have also increasingly been detected in human samples, suggesting their zoonotic potential [7].

In conclusion, the results of our study showed that E. bieneusi infection occurs in children in Xinjiang, China. Unusually, genotype NIA1 was identified as the most prevalent genotype among the fecal samples examined. Further epidemiological studies need to be conducted to confirm the animal origin of E. bieneusi infection in this area.

Supporting information

S1 Checklist. STROBE Statement.

Checklist of items that should be included in reports of observational studies.

(DOCX)

Acknowledgments

We thank Liwen Bianji, Edanz Editing China (www.liwenbianji.cn/ac), for editing the English text of a draft of this manuscript.

Data Availability

The datasets generated for this study can be found in the GenBank under the accession numbers MN136770–MN136778.

Funding Statement

This work was supported in part by the National Natural Science Foundation of China (31860699), the National Key Research and Development Program of China (2017YFD0500405, 2017YFD0501305), and the Program for Young and Middle-Aged Leading Science, Technology, and Innovation of Xinjiang Production & Construction Group (2018CB034). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Santín M, Calero-Bernal R, Carmena D, Mateo M, Balseiro A, Barral M, et al. Molecular characterization of Enterocytozoon bieneusi in wild carnivores in Spain. J Eukaryot Microbiol. 2017. 10.1111/jeu.12492 . [DOI] [PubMed] [Google Scholar]
  • 2.Didier ES, Weiss LM. Microsporidiosis: not just in AIDS patients. Curr Opin Infect Dis. 2011;24:490–5. 10.1097/QCO.0b013e32834aa152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Wang S, Wang R, Fan X, Liu T, Zhang L, Zhao G. Prevalence and genotypes of Enterocytozoon bieneusi in China. Acta Trop. 2018;183:142–52. 10.1016/j.actatropica.2018.04.017 . [DOI] [PubMed] [Google Scholar]
  • 4.Li W, Feng Y, Santín M. Host specificity of Enterocytozoon bieneusi and public health implications. Trends Parasitol. 2019. 10.1016/j.pt.2019.04.004 . [DOI] [PubMed] [Google Scholar]
  • 5.Li N, Ayinmode AB, Zhang H, Feng Y, Xiao L. Host-adapted Cryptosporidium and Enterocytozoon bieneusi genotypes in straw-colored fruit bats in Nigeria. Int J Parasitol Parasites Wildl. 2019;8:19–24. Epub 2018/12/19. 10.1016/j.ijppaw.2018.12.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Zhang X, Wang Z, Su Y, Liang X, Sun X, Peng S, et al. Identification and genotyping of Enterocytozoon bieneusi in China. J Clin Microbiol. 2011;49:2006–8. 10.1128/JCM.00372-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Wang L, Xiao L, Duan L, Ye J, Guo Y, Guo M, et al. Concurrent infections of Giardia duodenalis, Enterocytozoon bieneusi, and Clostridium difficile in children during a cryptosporidiosis outbreak in a pediatric hospital in China. PLoS Negl Trop Dis. 2013;7:e2437 10.1371/journal.pntd.0002437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wang L, Zhang H, Zhao X, Zhang L, Zhang G, Guo M, et al. Zoonotic Cryptosporidium species and Enterocytozoon bieneusi genotypes in HIV-positive patients on antiretroviral therapy. J Clin Microbiol. 2013;51:557–63. 10.1128/JCM.02758-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Liu H, Shen Y, Yin J, Yuan Z, Jiang Y, Xu Y, et al. Prevalence and genetic characterization of Cryptosporidium, Enterocytozoon, Giardia and Cyclospora in diarrheal outpatients in China. BMC Infect Dis. 2014;14:25 Epub 2014/01/15. 10.1186/1471-2334-14-25 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Yang J, Song M, Wan Q, Li Y, Lu Y, Jiang Y, et al. Enterocytozoon bieneusi genotypes in children in Northeast China and assessment of risk of zoonotic transmission. J Clin Microbiol. 2014;52:4363–7. 10.1128/JCM.02295-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Liu H, Jiang Z, Yuan Z, Yin J, Wang Z, Yu B, et al. Infection by and genotype characteristics of Enterocytozoon bieneusi in HIV/AIDS patients from Guangxi Zhuang autonomous region, China. BMC Infect Dis. 2017;17:684 10.1186/s12879-017-2787-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Wang T, Fan Y, Koehler AV, Ma G, Li T, Hu M, et al. First survey of Cryptosporidium, Giardia and Enterocytozoon in diarrhoeic children from Wuhan, China. Infect Genet Evol. 2017;51:127–31. 10.1016/j.meegid.2017.03.006 . [DOI] [PubMed] [Google Scholar]
  • 13.Zhang W, Ren G, Zhao W, Yang Z, Shen Y, Sun Y, et al. Genotyping of Enterocytozoon bieneusi and subtyping of Blastocystis in cancer patients: relationship to diarrhea and assessment of zoonotic transmission. Front Microbiol. 2017;8:1835 10.3389/fmicb.2017.01835 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Ding S, Huang W, Qin Q, Tang J, Liu H. Genotype identification and phylogenetic analysis of Enterocytozoon bieneusi isolates from stool samples of diarrheic children. J Parasitol. 2018. 10.1645/17-108 . [DOI] [PubMed] [Google Scholar]
  • 15.Gong B, Yang Y, Liu X, Cao J, Xu M, Xu N, et al. First survey of Enterocytozoon bieneusi and dominant genotype Peru6 among ethnic minority groups in southwestern China’s Yunnan Province and assessment of risk factors. PLoS Negl Trop Dis. 2019;13:e0007356 10.1371/journal.pntd.0007356 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Sulaiman IM, Fayer R, Yang C, Santín M, Matos O, Xiao L. Molecular characterization of Enterocytozoon bieneusi in cattle indicates that only some isolates have zoonotic potential. Parasitol Res. 2004;92:328–34. 10.1007/s00436-003-1049-5 . [DOI] [PubMed] [Google Scholar]
  • 17.Qiu L, Xia W, Li W, Ping J, Ding S, Liu H. The prevalence of microsporidia in China: A systematic review and meta-analysis. Sci Rep. 2019;9:3174 10.1038/s41598-019-39290-3 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Espern A, Morio F, Miegeville M, Illa H, Abdoulaye M, Meyssonnier V, et al. Molecular study of microsporidiosis due to Enterocytozoon bieneusi and Encephalitozoon intestinalis among human immunodeficiency virus-infected patients from two geographical areas: Niamey, Niger, and Hanoi, Vietnam. J Clin Microbiol. 2007;45:2999–3002. 10.1128/JCM.00684-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Wumba R, Longo-Mbenza B, Mandina M, Odio Wobin T, Biligui S, Sala J, et al. Intestinal parasites infections in hospitalized AIDS patients in Kinshasa, Democratic Republic of Congo. Parasite. 2010;17:321–8. 10.1051/parasite/2010174321 . [DOI] [PubMed] [Google Scholar]
  • 20.Feng Y, Li N, Dearen T, Lobo ML, Matos O, Cama V, et al. Development of a multilocus sequence typing tool for high-resolution genotyping of Enterocytozoon bieneusi. Appl Environ Microbiol. 2011;77:4822–8. 10.1128/AEM.02803-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Wumba R, Longo-Mbenza B, Menotti J, Mandina M, Kintoki F, Situakibanza NH, et al. Epidemiology, clinical, immune, and molecular profiles of microsporidiosis and cryptosporidiosis among HIV/AIDS patients. Int J Gen Med. 2012;5:603–11. 10.2147/IJGM.S32344 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Li N, Xiao L, Wang L, Zhao S, Zhao X, Duan L, et al. Molecular surveillance of Cryptosporidium spp., Giardia duodenalis, and Enterocytozoon bieneusi by genotyping and subtyping parasites in wastewater. PLoS Negl Trop Dis. 2012;6:e1809 10.1371/journal.pntd.0001809 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Hu Y, Feng Y, Huang C, Xiao L. Occurrence, source, and human infection potential of Cryptosporidium and Enterocytozoon bieneusi in drinking source water in Shanghai, China, during a pig carcass disposal incident. Environ Sci Technol. 2014;48:14219–27. 10.1021/es504464t [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Huang C, Hu Y, Wang L, Wang Y, Li N, Guo Y, et al. Environmental transport of emerging human-pathogenic Cryptosporidium species and subtypes through combined sewer overflow and wastewater. Appl Environ Microbiol. 2017;83 10.1128/AEM.00682-17 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Ben Ayed L, Yang W, Widmer G, Cama V, Ortega Y, Xiao L. Survey and genetic characterization of wastewater in Tunisia for Cryptosporidium spp., Giardia duodenalis, Enterocytozoon bieneusi, Cyclospora cayetanensis and Eimeria spp. J Water Health. 2012;10:431–44. 10.2166/wh.2012.204 . [DOI] [PubMed] [Google Scholar]
  • 26.Galván AL, Magnet A, Izquierdo F, Fenoy S, Rueda C, Fernández Vadillo C, et al. Molecular characterization of human-pathogenic microsporidia and Cyclospora cayetanensis isolated from various water sources in Spain: a year-long longitudinal study. Appl Environ Microbiol. 2013;79:449–59. 10.1128/AEM.02737-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Breitenmoser AC, Mathis A, Bürgi E, Weber R, Deplazes P. High prevalence of Enterocytozoon bieneusi in swine with four genotypes that differ from those identified in humans. Parasitology. 1999;118:447–53. 10.1017/s0031182099004229 . [DOI] [PubMed] [Google Scholar]
  • 28.Li W, Kiulia NM, Mwenda JM, Nyachieo A, Taylor MB, Zhang X, et al. Cyclospora papionis, Cryptosporidium hominis, and human-pathogenic Enterocytozoon bieneusi in captive baboons in Kenya. J Clin Microbiol. 2011;49:4326–9. 10.1128/JCM.05051-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Li D, Zhang Y, Jiang Y, Xing J, Tao D, Zhao A, et al. Genotyping and Zoonotic Potential of Enterocytozoon bieneusi in Pigs in Xinjiang, China. Front Microbiol. 2019. 10:2401 10.3389/fmicb.2019.02401 [DOI] [PMC free article] [PubMed] [Google Scholar]
PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008293.r001

Decision Letter 0

Todd B Reynolds, Abdallah M Samy

31 Jan 2020

Dear Dr. Zhang,

Thank you very much for submitting your manuscript "Unusual dominant genotype NIA1 of Enterocytozoon bieneusi in children in Southern Xinjiang, China" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Abdallah M. Samy, PhD

Guest Editor

PLOS Neglected Tropical Diseases

Todd Reynolds

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Editor comments to authors: I invited four reviews for your manuscript; however, we received only three reviews and experienced a delay in receiving the fourth review. My decision is to terminate the review task of this fourth review to avoid any further delay on this manuscript. Please consider all comments addressed by reviewers below before submitting a revised version of your manuscript. Thanks! AMS

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? YES

-Is the study design appropriate to address the stated objectives? YES

-Is the population clearly described and appropriate for the hypothesis being tested? NO

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? YES

-Were correct statistical analysis used to support conclusions? YES

-Are there concerns about ethical or regulatory requirements being met? NO

"Comments to the Author":

Keywords:

- Add: novel genotypes.

Abstract:

- Lines 16-17: “Enterocytozoon bieneusi causes approximately 90% of reported cases of human microsporidiosis”. Add: “mainly pathologies or intestinal disorders”.

Author summary:

- Lines 40-41: “Additionally, we demonstrated the zoonotic potential of E. bieneusi genotype D..”. Change: I prefer to use “we confirmed” or “we contrasted”.

- Comment: The authors must mention the groups 1 and 2 for grouping the nine identified genotypes and highlight the three novel genotypes.

Introduction:

- Line 48: “may cause persistent diarrhea, vomiting and a wasting síndrome”. Add: “dissemination and presence in other organs”.

- Lines 57-58. Comment: The zoonotic role of group 2 and mainly of group 1 should be highlighted. Finally, cite risk factors, sources of infection and animal hosts (reservoirs).

- Line 64: “in China have been reported by several studies”. Add: references [6-14]?.

Materials and Methods:

- Ethics statements: Lines 82-83. “Participants infected with parasites received 83 appropriate treatment according to local policies and national guidelines”. Comment: It is unknown if patients have an active infection or are spores passing through the intestine without causing a real infection in the patient. I prefer to remove “Participants infected” and put “Participants with possible presence of parasites” or “Positive participants in the study with parasites”.

- Sample collection: Lines 86-87. In my opinion it would be very important to indicate if the counties studied are in urban or rural areas. This information would help a greater knowledge of the circulation of different genotypes according to the type of area and the presence or absence of animal hosts as a source of infection.

- Sample collection: Line 91. “No diarrhea was observed during sampling”. Comment: It should be indicated if children have any other signs or symptoms, for example, weight loss, malnutrition, fever, etc. or even some other associated pathology (if this would be possible).

- DNA extraction and PCR amplification. The authors should provide some additional nested PCR information. For example, the pairs of primers used, temperature cycles, independently of the bibliographic references.

Reviewer #2: 1.the sample collection is from 11 counties of Xinjiang ,China, suggest to use a map to fix location.

2."the studies were conducted in diverse geographical locations (Jilin, Heilongjiang, Guangxi, Henan, Shanghai, Hubei, and Chongqing)", need to supply more references, such as PLoS Negl Trop Dis 13(5): e0007356. https://doi.org/10.1371/journal.pntd.0007356.

Reviewer #3: (No Response)

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: -Does the analysis presented match the analysis plan?.

Yes.

-Are the results clearly and completely presented?

Phylogenetic analysis: Lines 163-164. “(CHN6, CXJH2, and CXJH3) clustered together with the zoonotic genotypes I, J, and BEB6 (Figure 1)”. Add: group 2.

-Are the figures (Tables, Images) of sufficient quality for clarity?

Table 1: Indicate the urban or rural character of the counties studied.

Reviewer #2: 1.the line 141, I think that it make a mistake, "age groupe"? If so, please add it.

Reviewer #3: (No Response)

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: -Are the conclusions supported by the data presented? Review (comments below)

-Are the limitations of analysis clearly described? YES

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? NO

-Is public health relevance addressed? YES

The authors should modify the conclusions based on the new information provided in the Discussion.

For example:

- Line 201. Remember: In my opinion it would be very important to indicate if the counties studied are in urban or rural areas. This information would help a greater knowledge of the circulation of different genotypes according to the type of area and the presence or absence of animal hosts as a source of infection.

- The authors have recently published the following article that should be discussed in this section and included in the bibliography. “Li D-F, Zhang Y, Jiang Y-X, Xing J-M, Tao D-Y, Zhao AY, Cui Z-H, Jing B, Qi M and Zhang L-X (2019). Genotyping and Zoonotic Potential of Enterocytozoon bieneusi in Pigs in Xinjiang, China. Front. Microbiol. 10:2401. doi: 10.3389/fmicb.2019.02401”.

It is very important because the second genotype (D) and the fourth (EbpA) identified in children are those detected in pigs in the same geographical area of Xinjiang (China).

Therefore, it could reinforce the role or zoonotic character of some of the genotypes found in children and the importance of the geographical area (urban or rural).

Reviewer #2: this study conclusions are proper. the data of analysis is correct. the discuss can help to understanding the topics.

Reviewer #3: (No Response)

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: (No Response)

Reviewer #2: the objectives of study are very clear, and the sdudy design is appropriate toaddress the objectives.

Reviewer #3: (No Response)

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: Discussion:

- Line 184: “as in a study which found that 11 of 93 fecal specimens collected from children with”. Add: percentage (%).

- Line 199: “dominant genotype in children in Southern Xinjiang in this study”. Add: percentage (%).

- Line 201. Remember: In my opinion it would be very important to indicate if the counties studied are in urban or rural areas. This information would help a greater knowledge of the circulation of different genotypes according to the type of area and the presence or absence of animal hosts as a source of infection.

- Line 202: “Genotype D was the second most prevalent genotype detected in this study”. Add: percentage (%).

- The authors have recently published the following article that should be discussed in this section and included in the bibliography. “Li D-F, Zhang Y, Jiang Y-X, Xing J-M, Tao D-Y, Zhao AY, Cui Z-H, Jing B, Qi M and Zhang L-X (2019). Genotyping and Zoonotic Potential of Enterocytozoon bieneusi in Pigs in Xinjiang, China. Front. Microbiol. 10:2401. doi: 10.3389/fmicb.2019.02401”.

It is very important because the second genotype (D) and the fourth (EbpA) identified in children are those detected in pigs in the same geographical area of Xinjiang (China).

Therefore, it could reinforce the role or zoonotic character of some of the genotypes found in children and the importance of the geographical area (urban or rural).

References:

- Add: Li D-F, Zhang Y, Jiang Y-X, Xing J-M, Tao D-Y, Zhao A-Y, Cui Z-H, Jing B, Qi M and Zhang LX (2019). Genotyping and Zoonotic Potential of Enterocytozoon bieneusi in Pigs in Xinjiang, China. Front. Microbiol. 10:2401. doi: 10.3389/fmicb.2019.02401.

Reviewer #2: This study reports the zoonotic potential of E. bieneusi genotype D . this study is also the first report of human infection by E. bieneusi genotypes KB-1 and CHN6 in China. This is an important significance .

Reviewer #3: (No Response)

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Fernando Izquierdo Arias.

Área de Parasitología e Inmunología.

Facultad de Farmacia.

Universidad CEU-San Pablo.

Urbanización Montepríncipe.

28668 Boadilla del Monte, Madrid (Spain)

Teléfono: +34-91-372-47-00 (ext. 15275)

Fax: 91-351-04-96

e-mail: ferizqui@ceu.es

https://orcid.org/0000-0003-0367-007X

Publons: AAE-3073-2019

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see https://journals.plos.org/plosntds/s/submission-guidelines#loc-methods

Attachment

Submitted filename: Review comments.docx

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008293.r003

Decision Letter 1

Abdallah M Samy

10 Apr 2020

Dear Dr. Zhang,

Thank you very much for submitting your manuscript "Unusual dominant genotype NIA1 of Enterocytozoon bieneusi in children in Southern Xinjiang, China" for consideration at PLOS Neglected Tropical Diseases. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 7 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.  

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. 

Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Abdallah M. Samy, PhD

Deputy Editor

PLOS Neglected Tropical Diseases

Todd Reynolds

Deputy Editor

PLOS Neglected Tropical Diseases

***********************

Reviewer's Responses to Questions

Key Review Criteria Required for Acceptance?

As you describe the new analyses required for acceptance, please consider the following:

Methods

-Are the objectives of the study clearly articulated with a clear testable hypothesis stated?

-Is the study design appropriate to address the stated objectives?

-Is the population clearly described and appropriate for the hypothesis being tested?

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested?

-Were correct statistical analysis used to support conclusions?

-Are there concerns about ethical or regulatory requirements being met?

Reviewer #1: -Are the objectives of the study clearly articulated with a clear testable hypothesis stated? YES

-Is the study design appropriate to address the stated objectives? YES

-Is the population clearly described and appropriate for the hypothesis being tested? YES

-Is the sample size sufficient to ensure adequate power to address the hypothesis being tested? YES

-Were correct statistical analysis used to support conclusions? YES

-Are there concerns about ethical or regulatory requirements being met? NO

Reviewer #3: Yes

--------------------

Results

-Does the analysis presented match the analysis plan?

-Are the results clearly and completely presented?

-Are the figures (Tables, Images) of sufficient quality for clarity?

Reviewer #1: -Does the analysis presented match the analysis plan? YES

-Are the results clearly and completely presented? YES

-Are the figures (Tables, Images) of sufficient quality for clarity? YES

Reviewer #3: Yes

--------------------

Conclusions

-Are the conclusions supported by the data presented?

-Are the limitations of analysis clearly described?

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study?

-Is public health relevance addressed?

Reviewer #1: -Are the conclusions supported by the data presented? YES

-Are the limitations of analysis clearly described? YES

-Do the authors discuss how these data can be helpful to advance our understanding of the topic under study? YES

-Is public health relevance addressed? YES

Reviewer #3: Yes

--------------------

Editorial and Data Presentation Modifications?

Use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity. If the only modifications needed are minor and/or editorial, you may wish to recommend “Minor Revision” or “Accept”.

Reviewer #1: Comment:

Question 2: - Lines 16-17: “Enterocytozoon bieneusi causes approximately 90% of reported cases of human microsporidiosis”. Add: “mainly pathologies or intestinal disorders”. Response: Thank you very much. We have revised this. Seen in Line 16.

The authors must put all words “mainly pathologies or intestinal disorders”. In the manuscript is only "Enterocytozoon bieneusi is the mainly pathologies".

Reviewer #3: Accept

--------------------

Summary and General Comments

Use this section to provide overall comments, discuss strengths/weaknesses of the study, novelty, significance, general execution and scholarship. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. If requesting major revision, please articulate the new experiments that are needed.

Reviewer #1: Dear Authors:

I want to thank the authors for the changes done and congratulate them for the work and research presented in the article. And I encourage them to continue in the same line for clearing doubts about the circulation and prevalence of this parasite.

Reviewer #3: The author has already addressed the relevant questions and the authors have made the changes. I have just a few additional comments.

1. “unusual dominant genotype NIA1” is missing in the abstract, please add it.

2. Line 59, ‘of which 96 have been…’ should be revised to ‘of which more than 96 have been…’

3. Line 213, healthcare level also should be included here.

4. Line 251, ‘…isolates identified in ruminants.’. Revised word ‘isolates’ to ‘genotypes’.

--------------------

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: Yes: Dr. Fernando Izquierdo Arias.

Reviewer #3: Yes: Jianping Cao

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, PLOS recommends that you deposit laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. For instructions see http://journals.plos.org/plosntds/s/submission-guidelines#loc-materials-and-methods

Attachment

Submitted filename: Comments.docx

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008293.r005

Decision Letter 2

Abdallah M Samy

14 Apr 2020

Dear Dr. Zhang,

We are pleased to inform you that your manuscript 'Unusual dominant genotype NIA1 of Enterocytozoon bieneusi in children in Southern Xinjiang, China' has been provisionally accepted for publication in PLOS Neglected Tropical Diseases.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Abdallah M. Samy, PhD

Deputy Editor

PLOS Neglected Tropical Diseases

Todd Reynolds

Deputy Editor

PLOS Neglected Tropical Diseases

PLoS Negl Trop Dis. doi: 10.1371/journal.pntd.0008293.r006

Acceptance letter

Abdallah M Samy

12 Jun 2020

Dear Dr. Zhang,

We are delighted to inform you that your manuscript, "Unusual dominant genotype NIA1 of Enterocytozoon bieneusi in children in Southern Xinjiang, China," has been formally accepted for publication in PLOS Neglected Tropical Diseases.

We have now passed your article onto the PLOS Production Department who will complete the rest of the publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Editorial, Viewpoint, Symposium, Review, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript will be published online unless you opted out of this process. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Neglected Tropical Diseases.

Best regards,

Shaden Kamhawi

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Paul Brindley

co-Editor-in-Chief

PLOS Neglected Tropical Diseases

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Checklist. STROBE Statement.

    Checklist of items that should be included in reports of observational studies.

    (DOCX)

    Attachment

    Submitted filename: Review comments.docx

    Attachment

    Submitted filename: response to PNTD-S-19-02284.docx

    Attachment

    Submitted filename: Comments.docx

    Attachment

    Submitted filename: response to PNTD-S-19-02284-R2.docx

    Data Availability Statement

    The datasets generated for this study can be found in the GenBank under the accession numbers MN136770–MN136778.


    Articles from PLoS Neglected Tropical Diseases are provided here courtesy of PLOS

    RESOURCES